Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2006 Sep;92(9):1278-84.
doi: 10.1136/hrt.2005.075077. Epub 2006 Jan 31.

Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes

K Vijayalakshmi  1 , V J Whittaker, B Kunadian, J Graham, R A Wright, J A Hall, A Sutton, M A de Belder
Affiliations
Randomized Controlled Trial

Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes

K Vijayalakshmi et al. Heart. 2006 Sep.

Abstract

Objectives: To study the impact of injection of verapamil and adenosine in the coronary arteries on TIMI (Thrombolysis in Myocardial Infarction) frame count (TFC) after percutaneous coronary intervention (PCI) in patients with an acute coronary syndrome (ACS).

Methods: Prospective, randomised, controlled study of the intracoronary administration of normal saline versus verapamil versus adenosine in patients undergoing PCI in the setting of an ACS, even when flow is visually established to be normal or near normal. Patients were randomised to receive verapamil (n = 49), adenosine (n = 51) or normal saline (n = 50) after PCI. Quantitative angiography, TIMI flow grade (TFG), TFC and myocardial blush grade were assessed before PCI, after PCI and after drugs were given. Wall motion index (WMI) was measured at days 1 and 30.

Results: 9 patients in the verapamil group developed transient heart block, not seen with adenosine (p <or= 0.001). Compared with saline, coronary flow measured by TFC improved significantly and WMI improved slightly but insignificantly in both the verapamil (TFC: p = 0.02; mean difference in improvement in WMI: 0.09, 95% confidence interval (CI) 0.015 to 0.17, p = 0.02) and the adenosine groups (TFC: p = 0.002; mean difference in improvement in WMI: 0.08, 95% CI 0.004 to 0.16, p = 0.04). The improvements in TFC and WMI did not differ significantly between the verapamil and the adenosine groups (TFC: p = 0.2; mean difference in improvement in WMI: 0.01, 95% CI -0.055 to 0.08, p = 0.7, respectively).

Conclusion: Administration of verapamil or adenosine significantly improves coronary flow and WMI after PCI in the setting of an ACS. Flow and WMI did not differ significantly between verapamil and adenosine but verapamil was associated with the development of transient heart block.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

References

    1. Piani R, Palik G, Moscucci M.et al Incidence and treatment of ‘no‐reflow' after percutaneous coronary intervention. Circulation 1994892514–2518. - PubMed
    1. Bates E, Krell M, Dean E.et al Demonstration of no‐reflow phenomenon by digital coronary arteriography. Am J Cardiol 198657177–178. - PubMed
    1. Feld H, Lichstein E, Schachter J.et al Early and late angiographic findings of the no‐reflow phenomenon following direct angioplasty as primary treatment for acute myocardial infarction. Am Heart J 1992123782–784. - PubMed
    1. Kloner R, Ganote C. The no‐reflow phenomenon after temporary occlusion in the dog. J Clin Invest 1974541508 - PMC - PubMed
    1. Werner G, Lang K, Kuehnert H.et al Intracoronary verapamil for reversal of no‐reflow during coronary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 200257444–451. - PubMed

Publication types